Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.700
-0.050 (-1.82%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Zentalis Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Sep 15, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $8 | Buy | Reiterates | $8 | +196.30% | Aug 11, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $4 → $5 | Hold | Maintains | $4 → $5 | +85.19% | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $10 | Buy | Maintains | $10 | +270.37% | Aug 7, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $10 | Buy | Maintains | $10 | +270.37% | Aug 7, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $11 | Buy | Initiates | $11 | +307.41% | Jul 23, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $9 | Buy | Initiates | $9 | +233.33% | Jun 15, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Hold Maintains $4 | Hold | Maintains | $4 | +48.15% | May 13, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.